MedsFacts.com - the Next-Generation Reference for Medication Safety.
MedsFacts is a unique online community for patients, health care providers, and medical researchers.
Our goal is to provide valuable information for the 60% of Americans (and others worldwide) currently taking prescription drugs.
Easy to use online research interface helps you quickly assess the benefits and potential danger of various treatments.
Analysis of the latest Food & Drug Administration data covers over 18 million drug side effect profiles.
Interactive tools to allow you to collaborate with others to learn more about medications.
Make more informed treatment decisions knowing you consulted MedsFacts analytics - medical research studies that scrutinize drug safety reports.
MedsFacts is a free service, as we believe the usefulness of our platform scales as more people interact with our service.

About this MedsFacts analysis covering adverse side effect reports of LAMOTRIGINE patients who developed PHARMACEUTICAL PRODUCT COUNTERFEIT.

MedsFacts provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and MedsFacts user submissions. Between January 2004 and October 2012, 2 individuals taking LAMOTRIGINE reported PHARMACEUTICAL PRODUCT COUNTERFEIT to the FDA. A total of 13265 LAMOTRIGINE drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between LAMOTRIGINE and PHARMACEUTICAL PRODUCT COUNTERFEIT. In doing so, we compare LAMOTRIGINE with other drugs that cause PHARMACEUTICAL PRODUCT COUNTERFEIT, to help you evaluate whether or not LAMOTRIGINE causes PHARMACEUTICAL PRODUCT COUNTERFEIT. Likewise, this page shows the most highly-reported side effects of LAMOTRIGINE, so you can see if PHARMACEUTICAL PRODUCT COUNTERFEIT ranks among LAMOTRIGINE's most well-known side effects.
Summary Statistics
Reports of LAMOTRIGINE causing PHARMACEUTICAL PRODUCT COUNTERFEIT: 2
Reports of any side effect of LAMOTRIGINE : 13265
Percentage of LAMOTRIGINE patients where PHARMACEUTICAL PRODUCT COUNTERFEIT is a reported side effect: 0.0151%

FDA reports of any drug causing PHARMACEUTICAL PRODUCT COUNTERFEIT : 292
Average percentage for all medicated patients where PHARMACEUTICAL PRODUCT COUNTERFEIT is reported as a complication: 0.0018%

Physician opinion on LAMOTRIGINE as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing LAMOTRIGINE:
EPILEPSY ( 2366 patients )
BIPOLAR DISORDER ( 1043 patients )
CONVULSION ( 773 patients )
PRODUCT USED FOR UNKNOWN INDICATION ( 646 patients )
DRUG USE FOR UNKNOWN INDICATION ( 550 patients )
DEPRESSION ( 373 patients )
AFFECTIVE DISORDER ( 159 patients )
GRAND MAL CONVULSION ( 118 patients )
PARTIAL SEIZURES ( 116 patients )
BIPOLAR I DISORDER ( 107 patients )
BIPOLAR II DISORDER ( 82 patients )
DRUG EXPOSURE DURING PREGNANCY ( 80 patients )
SCHIZOPHRENIA ( 73 patients )
COMPLEX PARTIAL SEIZURES ( 67 patients )
MOOD SWINGS ( 56 patients )
MYOCLONIC EPILEPSY ( 49 patients )
PETIT MAL EPILEPSY ( 46 patients )
MAJOR DEPRESSION ( 45 patients )
ILL-DEFINED DISORDER ( 43 patients )
MOOD ALTERED ( 42 patients )
TEMPORAL LOBE EPILEPSY ( 42 patients )
SCHIZOAFFECTIVE DISORDER ( 39 patients )
MIGRAINE ( 36 patients )
BORDERLINE PERSONALITY DISORDER ( 33 patients )
PSYCHOTIC DISORDER ( 33 patients )
ANXIETY ( 31 patients )
INTENTIONAL OVERDOSE ( 30 patients )
NERVOUS SYSTEM DISORDER ( 24 patients )
SUICIDE ATTEMPT ( 22 patients )
FOETAL EXPOSURE DURING PREGNANCY ( 22 patients )
INFANTILE SPASMS ( 20 patients )
MATERNAL EXPOSURE DURING PREGNANCY ( 18 patients )
CONVULSION PROPHYLAXIS ( 18 patients )
DEPRESSED MOOD ( 18 patients )
TRIGEMINAL NEURALGIA ( 17 patients )
MENTAL DISORDER ( 17 patients )
STATUS EPILEPTICUS ( 16 patients )
LENNOX-GASTAUT SYNDROME ( 16 patients )
POST-TRAUMATIC STRESS DISORDER ( 16 patients )
MANIA ( 15 patients )
IDIOPATHIC GENERALISED EPILEPSY ( 15 patients )
SIMPLE PARTIAL SEIZURES ( 13 patients )
POST-TRAUMATIC EPILEPSY ( 11 patients )
BACK PAIN ( 11 patients )
PAIN ( 11 patients )
OVERDOSE ( 10 patients )
ANTIDEPRESSANT THERAPY ( 10 patients )
DRUG THERAPY ( 9 patients )
HALLUCINATION ( 9 patients )
ABNORMAL BEHAVIOUR ( 8 patients )
MIGRAINE PROPHYLAXIS ( 8 patients )
POISONING DELIBERATE ( 8 patients )
FRONTAL LOBE EPILEPSY ( 7 patients )
SCHIZOPHRENIA, PARANOID TYPE ( 7 patients )
ACCIDENTAL OVERDOSE ( 6 patients )
TRAUMATIC BRAIN INJURY ( 6 patients )
MOOD DISORDER DUE TO A GENERAL MEDICAL CONDITION ( 6 patients )
SUICIDAL IDEATION ( 6 patients )
COMPLETED SUICIDE ( 6 patients )
ATTENTION DEFICIT/HYPERACTIVITY DISORDER ( 5 patients )
PANIC ATTACK ( 5 patients )
INTRACRANIAL INJURY ( 5 patients )
HEADACHE ( 5 patients )
DRUG EXPOSURE VIA BREAST MILK ( 4 patients )
CENTRAL NERVOUS SYSTEM LESION ( 4 patients )
IRRITABILITY ( 4 patients )
ANGER ( 4 patients )
PROPHYLAXIS ( 4 patients )
NEURALGIA ( 4 patients )
DYSTHYMIC DISORDER ( 4 patients )
MATERNAL EXPOSURE TIMING UNSPECIFIED ( 4 patients )
AFFECT LABILITY ( 3 patients )
DIABETIC NEUROPATHY ( 3 patients )
CONVERSION DISORDER ( 3 patients )
MYOCLONUS ( 3 patients )
PSYCHIATRIC SYMPTOM ( 3 patients )
CARDIAC DISORDER ( 3 patients )
PARTIAL SEIZURES WITH SECONDARY GENERALISATION ( 3 patients )
INSOMNIA ( 3 patients )
DEPRESSIVE SYMPTOM ( 3 patients )
JUVENILE MYOCLONIC EPILEPSY ( 3 patients )
MULTIPLE SCLEROSIS ( 3 patients )
BLOOD CHOLESTEROL ABNORMAL ( 3 patients )
DROP ATTACKS ( 3 patients )
FACIAL SPASM ( 3 patients )
GENERALISED NON-CONVULSIVE EPILEPSY ( 2 patients )
PERSONALITY DISORDER ( 2 patients )
STRESS ( 2 patients )
NEUROPATHY PERIPHERAL ( 2 patients )
OBSESSIVE-COMPULSIVE DISORDER ( 2 patients )
HALLUCINATION, AUDITORY ( 2 patients )
COGNITIVE DISORDER ( 2 patients )
HEMIPLEGIA ( 2 patients )
MUSCLE DISORDER ( 2 patients )
TONIC CONVULSION ( 2 patients )
SENSORY DISTURBANCE ( 2 patients )
EXPOSURE DURING BREAST FEEDING ( 2 patients )
PREMENSTRUAL SYNDROME ( 2 patients )
MENSTRUAL DISORDER ( 2 patients )
STARING ( 2 patients )
CYCLOTHYMIC DISORDER ( 2 patients )
GENERAL SYMPTOM ( 2 patients )
NEUROPATHIC PAIN ( 2 patients )
PSYCHOSOMATIC DISEASE ( 2 patients )
GLIOBLASTOMA MULTIFORME ( 2 patients )
CEREBRAL PALSY ( 2 patients )
DRUG WITHDRAWAL CONVULSIONS ( 2 patients )
AUTISM ( 2 patients )
CLONIC CONVULSION ( 2 patients )
POST HERPETIC NEURALGIA ( 2 patients )
ALCOHOLISM ( 2 patients )
ENCEPHALOPATHY ( 2 patients )
MATERNAL CONDITION AFFECTING FOETUS ( 2 patients )
CONFUSIONAL STATE ( 2 patients )
HYPOMANIA ( 2 patients )
PANIC DISORDER ( 2 patients )
BRAIN INJURY ( 2 patients )
CROHN'S DISEASE ( 2 patients )
IMPULSIVE BEHAVIOUR ( 1 patients )
PROSTATE CANCER ( 1 patients )
VENOUS ANGIOMA OF BRAIN ( 1 patients )
CARBOHYDRATE METABOLISM DISORDER ( 1 patients )
MICROCEPHALY ( 1 patients )
ARTHRITIS ( 1 patients )
DELUSIONAL DISORDER, UNSPECIFIED TYPE ( 1 patients )
NEUROFIBROMATOSIS ( 1 patients )
PSYCHOMOTOR SEIZURES ( 1 patients )
CATATONIA ( 1 patients )
DRUG THERAPY CHANGED ( 1 patients )
ASTROCYTOMA ( 1 patients )
DEMENTIA ALZHEIMER'S TYPE ( 1 patients )
PSYCHOTIC BEHAVIOUR ( 1 patients )
ACUTE PSYCHOSIS ( 1 patients )
PHARYNGITIS ( 1 patients )
SUBDURAL HAEMATOMA ( 1 patients )
PSYCHOTIC DISORDER DUE TO A GENERAL MEDICAL CONDITION ( 1 patients )
CEREBROVASCULAR ACCIDENT ( 1 patients )
DYSKINESIA ( 1 patients )
POLYCYSTIC OVARIES ( 1 patients )
AUTISM SPECTRUM DISORDER ( 1 patients )
ORTHOSTATIC INTOLERANCE ( 1 patients )
AICARDI'S SYNDROME ( 1 patients )
ENCEPHALITIS ( 1 patients )
TEMPERATURE REGULATION DISORDER ( 1 patients )
DISORIENTATION ( 1 patients )
SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS ( 1 patients )
AMNESIA ( 1 patients )
HYPERTENSION ( 1 patients )
MYELITIS TRANSVERSE ( 1 patients )
POSTPARTUM DEPRESSION ( 1 patients )
DIZZINESS ( 1 patients )
DRUG ABUSER ( 1 patients )
PANIC REACTION ( 1 patients )
SLEEP DISORDER ( 1 patients )
FEBRILE CONVULSION ( 1 patients )
IMPULSE-CONTROL DISORDER ( 1 patients )
NARCOLEPSY ( 1 patients )
VASCULAR OPERATION ( 1 patients )
BRAIN LOBECTOMY ( 1 patients )
MENTAL RETARDATION ( 1 patients )
PARKINSON'S DISEASE ( 1 patients )
ANXIOLYTIC THERAPY ( 1 patients )
INCORRECT DOSE ADMINISTERED ( 1 patients )
VERTIGO ( 1 patients )
MID-LIFE CRISIS ( 1 patients )
STREPTOCOCCUS TEST POSITIVE ( 1 patients )
ASTHENIA ( 1 patients )
DEMENTIA ( 1 patients )
ACQUIRED EPILEPTIC APHASIA ( 1 patients )
CELLULITIS ( 1 patients )
DRUG TOXICITY ( 1 patients )
STURGE-WEBER SYNDROME ( 1 patients )
ATONIC SEIZURES ( 1 patients )
NO THERAPEUTIC RESPONSE ( 1 patients )
ADJUSTMENT DISORDER WITH DEPRESSED MOOD ( 1 patients )
OFF LABEL USE ( 1 patients )
SUPPLEMENTATION THERAPY ( 1 patients )
DISEASE RECURRENCE ( 1 patients )
OSTEOARTHRITIS ( 1 patients )
HOLOPROSENCEPHALY ( 1 patients )
MUSCLE TWITCHING ( 1 patients )
DISTURBANCE IN ATTENTION ( 1 patients )
SEIZURE CLUSTER ( 1 patients )
ANGELMAN'S SYNDROME ( 1 patients )
EUPHORIC MOOD ( 1 patients )
PRE-ECLAMPSIA ( 1 patients )
TOXIC EPIDERMAL NECROLYSIS ( 1 patients )
ANTICONVULSANT DRUG LEVEL ( 1 patients )
MYOTONIA ( 1 patients )
DRUG DEPENDENCE ( 1 patients )
PARAESTHESIA ( 1 patients )
SOMNOLENCE ( 1 patients )
FEELING OF RELAXATION ( 1 patients )
( 0 patients )
Drugs with high FDA adverse event association with PHARMACEUTICAL PRODUCT COUNTERFEIT:

REOPRO (26 patients)
DEPAKENE (25 patients)
LIPITOR (24 patients)
VALIUM (12 patients)
TYLENOL (CAPLET) (11 patients)
MIDAZOLAM HCL (11 patients)
REMICADE (10 patients)
HEPARIN (10 patients)
DIAZEPAM (8 patients)
FENTANYL-100 (8 patients)
CELEBREX (7 patients)
VIAGRA (7 patients)
VALPROATE SODIUM (6 patients)
CONCERTA (6 patients)
VITAMIN B (6 patients)
MORPHINE (6 patients)
MS CONTIN (6 patients)
NORVASC (6 patients)
PREMARIN (5 patients)
ANTUSS INFANTS DECONGESTANT + COUGH (5 patients)
ATIVAN (5 patients)
PROZAC (5 patients)
TRICOR (5 patients)
ZOLPIDEM (5 patients)
INFLIXIMAB (5 patients)
PREMPRO (4 patients)
ALDACTONE (4 patients)
AMBIEN (4 patients)
CHILDREN'S MOTRIN (4 patients)
DIOVAN HCT (4 patients)
IMODIUM ADVANCED (4 patients)
TRAZODONE HCL (4 patients)
METFORMIN HCL (4 patients)
PHENYTOIN (4 patients)
ACETYLSALICYLIC ACID SRT (3 patients)
AMITRIPTYLINE HCL (3 patients)
ASPIRIN (3 patients)
CELESTONE SOLUSPAN (3 patients)
CHILDRENS TYLENOL PLUS COLD AND COUGH ORAL (3 patients)
CIALIS (3 patients)
COGENTIN (3 patients)
DIABETIC MEDICATIONS (3 patients)
DIOVAN (3 patients)
DRISDOL (3 patients)
FACTOR IX COMPLEX (3 patients)
GEODON (3 patients)
RISPERDAL (3 patients)
TRAMADOL HCL (3 patients)
KLONOPIN (3 patients)
LEXAPRO (3 patients)
MICRONOR (3 patients)
MULTIVITAMIN (3 patients)
NIZATIDINE (3 patients)
OXYCONTIN (3 patients)
ACETAMINOPHEN AND HYDROCODONE BITARTRATE (2 patients)
AGGRASTAT (2 patients)
ALBUTEROL (2 patients)
PROVIGIL (2 patients)
AMLODIPINE BESYLATE (2 patients)
AMOXICILLIN (2 patients)
ANTI-DIABETICS (ANTI-DIABETICS) (2 patients)
ANTIHEMOPHILIC FACTOR (HUMAN) (2 patients)
ATENOLOL (2 patients)
AVAPRO (2 patients)
AVODART (2 patients)
TIAZAC (2 patients)
BROMOCRIPTINE MESYLATE (2 patients)
BUMINATE 25% (2 patients)
CALCIUM WITH VITAMIN D (CALCIUM PHOSPHATE, CALCIUM SODIUM LACTATE, ERG (2 patients)
CARBAMAZEPINE (2 patients)
CIPROFLOXACIN (2 patients)
QUININE SULFATE (2 patients)
RANITIDINE (2 patients)
SUSPECTED COUNTERFEIT OF PLAVIX (2 patients)
SUSPECTED COUNTERFEIT OF ZOLPIDEM GENERIC (2 patients)
TOPAMAX (2 patients)
DEMEROL (2 patients)
TYLENOL W/ CODEINE (2 patients)
DILANTIN (2 patients)
DILANTIN KAPSEAL (2 patients)
EPAMIN (PHENYTOIN SODIUM) (2 patients)
EXTRA STRENGTH TYLENOL (2 patients)
FAMVIR (2 patients)
FENTANYL (2 patients)
FENTANYL CITRATE (2 patients)
FLOMAX (2 patients)
FOSAMAX (2 patients)
FUROSEMIDE (2 patients)
GABAPENTIN (2 patients)
GEMFIBROZIL (2 patients)
HYDROCODONE (HYDROCODONE) (2 patients)
HYDROCODONE BITARTRATE + ACETAMINOPHEN (2 patients)
TAMSULOSIN HCL (2 patients)
IMODIUM (2 patients)
KLONOPIN LYOPHILIZED WAFERS (2 patients)
VITAMIN CAP (2 patients)
WELLBUTRIN (2 patients)
LAMISIL (2 patients)
LAMOTRIGINE (2 patients)
LASIX (2 patients)
LIDOCAINE (2 patients)
LO/OVRAL (2 patients)
LOVASTATIN (2 patients)
MARCAINE (2 patients)
MAXALT-MLT (2 patients)
METOPROLOL SUCCINATE (2 patients)
MIRALAX (2 patients)
MOISTURIZING SALINE NASAL SPRAY^ ^DEEP SEA PREMIUM MAJOR PHARMACEUTICA (2 patients)
NEURONTIN (2 patients)
NITROGLYCERIN (2 patients)
ORTHO EVRA (2 patients)
OXYCODONE AND ACETAMINOPHEN (2 patients)
PEPCID COMPLETE (2 patients)
PHENOBARBITAL TAB (2 patients)
PHENTERMINE (2 patients)
PLENDIL (2 patients)
PRAVACHOL (2 patients)
ACTOS (1 patients)
ADDERALL 20 (1 patients)
ALL OTHER NON-THERAPEUTIC PRODUCTS (1 patients)
ALLERGY SHOTS (1 patients)
ALLOPURINOL (1 patients)
ALPRAZOLAM (1 patients)
ALTACE (1 patients)
AMPHETAMINE SALT TAB 10 MG CALIFORNIA PHARMACY (1 patients)
AMPHETAMINE SULFATE (1 patients)
ARIMIDEX (1 patients)
ASCORBIC ACID (1 patients)
AUGMENTIN '125' (1 patients)
BUPROPION HCL (1 patients)
CALCIUM (CALCIUM) (1 patients)
CALCIUM GLUCONATE (1 patients)
CASODEX (1 patients)
CAVERJECT (1 patients)
CEFZIL (1 patients)
CINNAMON OIL (1 patients)
CITALOPRAM HYDROBROMIDE (1 patients)
CLONAZEPAM (1 patients)
CLOPIDOGREL (1 patients)
COLCHICINE (1 patients)
COLD MEDICINE (1 patients)
COLGATE (1 patients)
COLGATE 0.76 SODIUM MONOFLUOROPHSPHAT COLGATE (1 patients)
COLGATE HERBAL TOOTHPASTE SODIUM MONOFLURPHOSPHATE COLGATE PALMOLIV (1 patients)
DICLOFENAC SODIUM (1 patients)
DIETHYLPROPION HCL (1 patients)
DIFLUNISAL (1 patients)
DIGOXIN (1 patients)
DITOPRAN XL (OXYBUTYNIN HYDROCHLORIDE) (1 patients)
DITROPAN XL (1 patients)
DURAGESIC (1 patients)
DURAGESIC-100 (1 patients)
DURATUSS ? ? (1 patients)
ENALAPRIL MALEATE (1 patients)
ENEMA (1 patients)
ESTRADIOL (1 patients)
ESTRATEST (1 patients)
ESTROGEN (ESTROGEN NOS) (1 patients)
EXTENDRYL JR ALLERGY (1 patients)
FACTOR IX (ALPHA THERAPEUTICS) (FACTOR IX) (1 patients)
FACTOR VIII (ARMOUR) (FACTOR VIII) (1 patients)
FACTOR VIII (AVENTIS BEHRING) (FACTOR VIII) (1 patients)
FAMOTIDINE (1 patients)
FENOFIBRATE (1 patients)
FENTANYL TRANSDERMAL SYSTEM (1 patients)
FISH OIL (1 patients)
FISH OIL (FISH OIL) (1 patients)
FLAXSEED (1 patients)
FLUOXETINE HCL (1 patients)
FLURAZEPAM (1 patients)
FORTUM (1 patients)
FRESHBURST LISTERINE (1 patients)
GENOTROPIN (1 patients)
GLIMEPIRIDE (1 patients)
GLUCONORM 0.5 MG (1 patients)
GLUCOPHAGE (1 patients)
GLUCOVANCE (1 patients)
ZYRTEC (1 patients)
LEVOTHROID (1 patients)
LISINOPRIL (1 patients)
LOVENOX (1 patients)
LUPRON DEPOT (1 patients)
LUPRON DEPOT-3 (1 patients)
MACRODANTINA (1 patients)
MELOXICAM (1 patients)
METHYLPREDNISOLONE 4MG TAB (1 patients)
METOPROLOL SUCCINATE EXTENDED RELEASE (1 patients)
MICRONASE (1 patients)
MOTRIN IB (1 patients)
MULTI-VITAMINS (1 patients)
NAPROSYN (1 patients)
NAPROXEN (1 patients)
NIFEDICAL (NIFEDIPINE) (1 patients)
NO CONCURRENT MEDICATIONS (1 patients)
NORFLOXACIN (1 patients)
NORPACE CR (1 patients)
NUTROPIN AQ (1 patients)
OLANZAPINE (1 patients)
OMACOR (1 patients)
OMEPRAZOLE (1 patients)
OXYCODONE HCL (1 patients)
OXYCODONE HCL EXTENDED-RELEASE (1 patients)
OXYMETAZOLINE HCL (1 patients)
OXYTROL (1 patients)
PAROXETINE (1 patients)
PAROXETINE HCL (1 patients)
PAXIL (1 patients)
PERCOCET (1 patients)
PHENYTOIN SODIUM (1 patients)
POLYETHYLENE GLYCOL 3350 (1 patients)
Most common side effects for patients taking LAMOTRIGINE:
CONVULSION (1551 patients)
DRUG EXPOSURE DURING PREGNANCY (911 patients)
DRUG INTERACTION (765 patients)
DRUG INEFFECTIVE (744 patients)
RASH (638 patients)
PYREXIA (591 patients)
DIZZINESS (554 patients)
COMPLETED SUICIDE (525 patients)
SOMNOLENCE (504 patients)
VOMITING (499 patients)
DEPRESSION (495 patients)
NAUSEA (493 patients)
HEADACHE (489 patients)
CONDITION AGGRAVATED (429 patients)
EPILEPSY (410 patients)
FATIGUE (409 patients)
GRAND MAL CONVULSION (402 patients)
PRODUCT SUBSTITUTION ISSUE (388 patients)
TREMOR (366 patients)
FALL (339 patients)
INSOMNIA (330 patients)
ANXIETY (329 patients)
CONFUSIONAL STATE (309 patients)
MATERNAL DRUGS AFFECTING FOETUS (301 patients)
DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS (301 patients)
STEVENS-JOHNSON SYNDROME (290 patients)
OVERDOSE (276 patients)
AGITATION (267 patients)
DYSPNOEA (266 patients)
MATERNAL EXPOSURE DURING PREGNANCY (264 patients)
DIARRHOEA (258 patients)
AGGRESSION (247 patients)
FEELING ABNORMAL (245 patients)
TOXICITY TO VARIOUS AGENTS (243 patients)
MALAISE (242 patients)
ASTHENIA (241 patients)
TACHYCARDIA (235 patients)
PAIN (231 patients)
BALANCE DISORDER (228 patients)
SUICIDE ATTEMPT (226 patients)
PLATELET COUNT DECREASED (223 patients)
VISION BLURRED (221 patients)
IRRITABILITY (220 patients)
DRUG TOXICITY (217 patients)
ABORTION SPONTANEOUS (215 patients)
CARDIAC ARREST (214 patients)
SUICIDAL IDEATION (211 patients)
PRURITUS (206 patients)
STATUS EPILEPTICUS (195 patients)
MEMORY IMPAIRMENT (194 patients)
WHITE BLOOD CELL COUNT DECREASED (191 patients)
ATAXIA (191 patients)
GAIT DISTURBANCE (189 patients)
WHITE BLOOD CELL COUNT INCREASED (189 patients)
LOSS OF CONSCIOUSNESS (188 patients)
HAEMOGLOBIN DECREASED (181 patients)
INTENTIONAL OVERDOSE (179 patients)
SPEECH DISORDER (172 patients)
HYPOTENSION (172 patients)
DEATH (168 patients)
WEIGHT DECREASED (168 patients)
WEIGHT INCREASED (167 patients)
ABNORMAL BEHAVIOUR (164 patients)
PNEUMONIA (164 patients)
THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION (164 patients)
THROMBOCYTOPENIA (162 patients)
CHEST PAIN (158 patients)
ABDOMINAL PAIN (152 patients)
NYSTAGMUS (152 patients)
CONSTIPATION (151 patients)
DEPRESSED LEVEL OF CONSCIOUSNESS (145 patients)
COGNITIVE DISORDER (144 patients)
DIPLOPIA (144 patients)
DISTURBANCE IN ATTENTION (143 patients)
ALANINE AMINOTRANSFERASE INCREASED (142 patients)
PRODUCT QUALITY ISSUE (142 patients)
RENAL FAILURE ACUTE (141 patients)
MENTAL IMPAIRMENT (140 patients)
BLOOD CREATINE PHOSPHOKINASE INCREASED (139 patients)
OEDEMA PERIPHERAL (137 patients)
RASH MACULO-PAPULAR (136 patients)
PARAESTHESIA (134 patients)
RHABDOMYOLYSIS (134 patients)
URINARY TRACT INFECTION (133 patients)
ATRIAL SEPTAL DEFECT (132 patients)
HYPONATRAEMIA (132 patients)
MYALGIA (129 patients)
DYSKINESIA (128 patients)
RENAL FAILURE (128 patients)
ENCEPHALOPATHY (127 patients)
LYMPHADENOPATHY (126 patients)
GENERAL PHYSICAL HEALTH DETERIORATION (125 patients)
RESPIRATORY ARREST (124 patients)
ARTHRALGIA (124 patients)
MANIA (124 patients)
CARDIO-RESPIRATORY ARREST (124 patients)
RASH ERYTHEMATOUS (123 patients)
LETHARGY (123 patients)
PREGNANCY (122 patients)
MYOCLONUS (121 patients)
DISORIENTATION (120 patients)
HALLUCINATION (120 patients)
METASTASES TO SPINE (120 patients)
LEUKOPENIA (119 patients)
NEUTROPENIA (118 patients)
BREAST ABSCESS (117 patients)
APHASIA (117 patients)
PSYCHOTIC DISORDER (116 patients)
DRUG HYPERSENSITIVITY (114 patients)
COMA (113 patients)
COORDINATION ABNORMAL (113 patients)
ERYTHEMA (112 patients)
PSYCHOMOTOR HYPERACTIVITY (111 patients)
BREAST CANCER (111 patients)
VENTRICULAR SEPTAL DEFECT (110 patients)
PETIT MAL EPILEPSY (110 patients)
FOETAL EXPOSURE DURING PREGNANCY (110 patients)
C-REACTIVE PROTEIN INCREASED (110 patients)
METABOLIC ACIDOSIS (109 patients)
ASPARTATE AMINOTRANSFERASE INCREASED (108 patients)
HYPERSENSITIVITY (106 patients)
AMNESIA (106 patients)
UNRESPONSIVE TO STIMULI (106 patients)
RASH GENERALISED (105 patients)
CRYING (104 patients)
DRUG LEVEL INCREASED (104 patients)
BACK PAIN (103 patients)
VISUAL IMPAIRMENT (102 patients)
COMPLEX PARTIAL SEIZURES (102 patients)
SEPSIS (102 patients)
HEART RATE INCREASED (102 patients)
DYSARTHRIA (102 patients)
DYSPHAGIA (98 patients)
SEROTONIN SYNDROME (98 patients)
BLISTER (98 patients)
ANGER (97 patients)
BODY TEMPERATURE INCREASED (97 patients)
MULTIPLE DRUG OVERDOSE INTENTIONAL (96 patients)
MOOD ALTERED (95 patients)
HYPOAESTHESIA (94 patients)
TALIPES (94 patients)
CHILLS (94 patients)
PREMATURE BABY (93 patients)
TOXIC EPIDERMAL NECROLYSIS (93 patients)
TREATMENT NONCOMPLIANCE (92 patients)
MULTI-ORGAN FAILURE (92 patients)
ALOPECIA (92 patients)
HYPERHIDROSIS (92 patients)
ABORTION INDUCED (91 patients)
SINUS TACHYCARDIA (91 patients)
BLOOD GLUCOSE INCREASED (90 patients)
ANAEMIA (90 patients)
URTICARIA (88 patients)
NEUROLEPTIC MALIGNANT SYNDROME (88 patients)
COUGH (88 patients)
VERTIGO (87 patients)
CAESAREAN SECTION (87 patients)
MENTAL DISORDER (87 patients)
SLEEP DISORDER (86 patients)
BIPOLAR DISORDER (86 patients)
NEUTROPHIL COUNT DECREASED (85 patients)
INCORRECT DOSE ADMINISTERED (85 patients)
HYPERTENSION (85 patients)
MUSCLE TWITCHING (84 patients)
WITHDRAWAL SYNDROME (83 patients)
DEHYDRATION (83 patients)
BLOOD PRESSURE INCREASED (83 patients)
SYNCOPE (82 patients)
MUSCLE SPASMS (82 patients)
PAIN IN EXTREMITY (82 patients)
HYPOXIA (81 patients)
OXYGEN SATURATION DECREASED (81 patients)
MOOD SWINGS (80 patients)
DISSEMINATED INTRAVASCULAR COAGULATION (80 patients)
MOVEMENT DISORDER (80 patients)
ELECTROCARDIOGRAM QT PROLONGED (80 patients)
DEPRESSED MOOD (79 patients)
LIVER FUNCTION TEST ABNORMAL (79 patients)
DRUG WITHDRAWAL SYNDROME (78 patients)
UPPER RESPIRATORY TRACT INFECTION (77 patients)
POISONING (77 patients)
SEDATION (77 patients)
GAMMA-GLUTAMYLTRANSFERASE INCREASED (76 patients)
HEPATIC ENZYME INCREASED (76 patients)
OFF LABEL USE (75 patients)
DRUG PRESCRIBING ERROR (75 patients)
INFLUENZA LIKE ILLNESS (75 patients)
RESTLESSNESS (75 patients)
JAUNDICE (75 patients)
DYSTONIA (75 patients)
DECREASED APPETITE (73 patients)
DIABETES MELLITUS (72 patients)
NEUTROPHIL COUNT INCREASED (72 patients)
MUSCULOSKELETAL STIFFNESS (72 patients)
ABDOMINAL PAIN UPPER (71 patients)
CONGENITAL ANOMALY (71 patients)
PARTIAL SEIZURES (71 patients)
BRAIN OEDEMA (71 patients)
RASH PRURITIC (69 patients)
PANIC ATTACK (69 patients)
NERVE INJURY (68 patients)
CYANOSIS (68 patients)
MENINGITIS ASEPTIC (67 patients)
INTENTIONAL SELF-INJURY (67 patients)
SKIN EXFOLIATION (67 patients)
ROAD TRAFFIC ACCIDENT (67 patients)
OCULOGYRIC CRISIS (67 patients)
ABSCESS (66 patients)
DRUG EFFECT DECREASED (66 patients)
DRY MOUTH (66 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the MedsFacts community - currently one million members and growing! MedsFacts online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent MedsFacts Activity for LAMOTRIGINE


Issue Description / Topic Timestamp

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited MedsFacts. If you have a question about PHARMACEUTICAL PRODUCT COUNTERFEIT and LAMOTRIGINE, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited MedsFacts. If you have a noteworthy experience as a patient taking LAMOTRIGINE, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults MedsFacts newest feature allows patients to consult - via realtime videoconferencing - experts in LAMOTRIGINE. This premium feature connects patients to experts, regardless of geography. MedsFacts experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for LAMOTRIGINE experts. If you are a healthcare provider experienced in prescribing LAMOTRIGINE, please register here.
© 2014 MedsFacts, Inc
Privacy Policy
Terms of Use